Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Praticien-chercheur
15 articles scientifiques publiés — formation continue solide
Cabinet de groupe — continuité de soins
Plusieurs praticiens dans le même cabinet — un confrère peut prendre le relais en cas d'absence
Délais de RDV courts dans la région
146.3 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
SELARL TIPHAINE LEDRUE
4 RUE SAINT ROCH, 31220 MARTRES TOLOSANE
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of nutritional science · 2013
AbstractElderly adults have alterations in their gut microbiota and immune functions that are associated with higher susceptibility to infections and metabolic disorders. Probiotics and prebiotics, and their synbiotic combinations are food supplements that have been shown to improve both gut and immune function. The objective of this randomised, double-blind, placebo-controlled, cross-over human clinical trial was to study immune function and the gut microbiota in healthy elderly adults. Volunteers (n37) consumed prebiotic galacto-oligosaccharides (GOS; 8 g/d), probioticBifidobacterium lactisBi-07 (Bi-07; 109colony-forming units/d), their combination (Bi-07 + GOS) and maltodextrin control (8 g/d) in four 3-week periods separated by 4-week wash-out periods. Immune function was analysed by determining the phagocytic and oxidative burst activity of monocytes and granulocytes, whole-blood response to lipopolysaccharide, plasma chemokine concentrations and salivary IgA levels. Gut microbiota composition and faecal SCFA content were determined using 16S ribosomal RNA fluorescencein situhybridisation and HPLC, respectively. Primary statistical analyses indicated the presence of carry-over effects and thus measurements from only the first supplementation period were considered valid. Subsequent statistical analysis showed that consumption of Bi-07 improved the phagocytic activity of monocytes (P < 0·001) and granulocytes (P = 0·02). Other parameters were unchanged. We have for the first time shown that the probiotic Bi-07 may provide health benefits to elderly individuals by improving the phagocytic activity of monocytes and granulocytes. The present results also suggest that in the elderly, the effects of some probiotics and prebiotics may last longer than in adults.
Pediatric blood & cancer · 2016
AbstractBackgroundIn 2012, new international guidelines for children with chemotherapy‐induced febrile neutropenia (FN) were issued, recommending reduced‐intensity management strategy based on stratification of infectious risks. Some studies have highlighted practice disparities in different countries and within the same country. Our aim was to assess the current management strategies for the treatment of chemotherapy‐induced FN in children in France.ProcedureThis survey of all French pediatric oncology‐hematology reference centers (n = 30) in late 2012 and early 2013 sent a standardized questionnaire to each center inquiring about their definition of an FN episode, its initial empiric treatment and ongoing management, use of management stratified by risk, and any criteria used for the risk assessment. Each center's management protocol was also analyzed.ResultsAll French reference centers participated in this survey, completing 88% of the questionnaire items. Definitions of both fever and neutropenia varied between centers. Ten centers used a risk‐stratification strategy for initial management. In all, 42 probabilistic first‐line antibiotic treatments were identified. After 48 hr of apyrexia, 17 units applied different forms of step‐down therapy.ConclusionsMost French centers already offered some form of reduced‐intensity or step‐down therapy, although they differed substantially in their management of FN episodes. Risk stratification with validated tools is essential to facilitate the implementation of the international recommendations, which would ultimately help to standardize practices in France.
Lupus · 2021
Introduction Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare phenomenon that leads to concomitant thrombosis and hemorrhage in children with SLE. LAHPS in pediatric SLE (pSLE) has a protracted course requiring long-term immunosuppressive therapy. Due to the rarity of this syndrome and paucity of reported cases, there is lack of standardized management. We herewith report 5 children with pSLE with LAHPS. Methodology: We retrospectively reviewed clinical features, laboratory features, treatment and outcome for 5 children with lupus anticoagulant hypoprothrombinemia syndrome with SLE and a review of literature of similar cases published. Results Mean age of presentation was 10.2 ± 2.38 years (mean ± SD) and female to male ratio was 4:1. All children presented with mild to severe bleeding manifestations like gum bleed, epistaxis, hematuria, menorrhagia and subarachnoid bleed. Coagulation profile revealed prolonged PT and aPTT, with low prothrombin levels and positive Lupus anticoagulant in all children. Mixing studies were characteristic in these children. On comparing laboratory parameters majority had low C3, C4 levels, ANA and anti-DsDNA antibody positivity and three children had anticardiolipin positivity. One child had lupus nephritis along with LAHPS at presentation. All responded well to steroids and supportive measures. Conclusion High index of suspicion is needed when child with lupus presents with bleeding manifestations for early diagnosis and treatment.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of orthopaedic case reports · 2024 · Case Reports
Palasseril AS, Chegu M, Shahul MR, T GM
Journal of orthopaedic case reports · 2021 · Case Reports
G S, John JT, Nair DS, Yadav S, et al.
Journal of orthopaedic case reports · 2016 · Case Reports
Ay GR, D SR, T C, C K, et al.
The Lancet. Child & adolescent health · 2022 · Journal Article
Delebarre M, Gonzales F, Behal H, Tiphaine A, et al.
Pediatric blood & cancer · 2016 · Journal Article
Delebarre M, Tiphaine A, Martinot A, Dubos F
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2016 · Journal Article
BMC rheumatology · 2020 · Journal Article
Sinha S, Ghosh B, Bandyopadhyay S, Fatima F, et al.
The Journal of the Association of Physicians of India · 2017 · Journal Article
Mathew AJ, Ganapati A, T SK, Goel R, et al.
Cureus · 2025 · Journal Article
Das S, Kotwal V, Thakur A, T L, et al.
Journal of nutritional science · 2013 · Journal Article
Maneerat S, Lehtinen MJ, Childs CE, Forssten SD, et al.
Cureus · 2024 · Case Reports
Nilofar F, Mohanasundaram K, Kumar M, T G
Lupus · 2021 · Case Reports
Kocheril AP, Vettiyil GI, George AS, Shah S, et al.
Cureus · 2025 · Journal Article
Das S, Kotwal V, Thakur A, T L, et al.
World journal of orthopedics · 2025 · Journal Article
Yeo PY, Kasivishvanaath A, Pérez-Carro L, T J
BMC rheumatology · 2020 · Journal Article
Sinha S, Ghosh B, Bandyopadhyay S, Fatima F, et al.
Journal of hand and microsurgery · 2022 · Journal Article
T J, Stewart CJ, Tong PY, Lam WL, et al.
Osteoarthritis and cartilage open · 2021 · Journal Article
A D, A T, T J, O R, et al.
Tiphaine Ade B, Hjalgrim LL, Nersting J, Breitkreutz J, et al.